Showing results (231-240 of 269) with videos related to
Sort By:
Pageof 27
Antiviral Research|December 3, 2016
Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivoKelly L Warfield, Travis K Warren, Xiangguo Qiu, et al.Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.Emerging Microbes & Infections|August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical diseaseDeclan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.Science Translational Medicine|December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primatesRuth Hunegnaw, Anna N Honko, Lingshu Wang, et al.Plos One|February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primatesBenoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.Plos One|April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primatesBenoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.Science Translational Medicine|April 7, 2017
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibodyChad E Mire, Joan B Geisbert, Viktoriya Borisevich, et al.Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.Pageof 27